Log In
BCIQ
Print this Print this
 

JDE-001

  Manage Alerts
Collapse Summary General Information
Company EyeGate Pharmaceuticals Inc.
Description0.4% cross-linked eye drop formulation of thiolated carboxymethyl hyaluronic acid (CMHA-S)
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationDry eye
Indication DetailsTreat dry eye
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today